Security key
23284F105
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX)
CUSIP: 23284F105
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value per share ("Common Stock")
- Shares outstanding
- 217,079,600
- Total 13F shares
- 35,594,054
- Share change
- -385,179
- Total reported value
- $53,751,153
- Put/Call ratio
- 244%
- Price per share
- $1.51
- Number of holders
- 74
- Value change
- -$933,381
- Number of buys
- 20
- Number of sells
- 45
Report period
Q1 2023
Institutions
74
Top holders
10
CTMX full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
CytomX Therapeutics, Inc. SEC filings
CytomX Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23284F105
Recent filing periods:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
3%
|
6,595,801
|
$10,553,282 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
4,585,721
|
$7,337,154 | — | 31 Dec 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.6%
|
3,510,445
|
$5,616,712 | — | 31 Dec 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,653,576
|
$4,244,000 | — | 31 Dec 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
1.1%
|
2,406,449
|
$3,850,318 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.79%
|
1,719,811
|
$2,752,000 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.62%
|
1,340,774
|
$2,145,000 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.6%
|
1,300,001
|
$2,080,002 | — | 31 Dec 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
0.59%
|
1,270,900
|
$2,033,440 | — | 31 Dec 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.42%
|
914,900
|
$1,464,000 | — | 31 Dec 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
740,724
|
$1,185,158 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
0.33%
|
716,646
|
$1,146,634 | — | 31 Dec 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.3%
|
661,892
|
$1,059,028 | — | 31 Dec 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.29%
|
635,798
|
$1,017,277 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.28%
|
618,374
|
$989,399 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
603,075
|
$964,000 | — | 31 Dec 2022 | |
| Newtyn Management, LLC |
13F
|
Company |
0.26%
|
570,000
|
$912,000 | — | 31 Dec 2022 | |
| Oasis Management Co Ltd. |
13F
|
Company |
0.25%
|
540,541
|
$864,866 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.24%
|
524,900
|
$839,840 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.21%
|
457,918
|
$732,669 | — | 31 Dec 2022 | |
| Tidal Investments LLC |
13F
|
Company |
0.16%
|
345,905
|
$553,000 | — | 31 Dec 2022 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.15%
|
318,233
|
$509,000 | — | 31 Dec 2022 | |
| Tejara Capital Ltd |
13F
|
Company |
0.11%
|
236,050
|
$377,680 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
223,976
|
$358,362 | — | 31 Dec 2022 | |
| Clearline Capital LP |
13F
|
Company |
0.09%
|
196,583
|
$314,533 | — | 31 Dec 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
176,000
|
$281,600 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
172,572
|
$276,000 | — | 31 Dec 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.08%
|
162,997
|
$261,000 | — | 31 Dec 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.07%
|
151,020
|
$241,632 | — | 31 Dec 2022 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.07%
|
148,354
|
$237,366 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
112,430
|
$179,888 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
103,924
|
$166,279 | — | 31 Dec 2022 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.04%
|
83,179
|
$62,753,000 | — | 31 Dec 2022 | |
| CM Management, LLC |
13F
|
Company |
0.03%
|
75,000
|
$120,000 | — | 31 Dec 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
69,600
|
$120,408 | — | 31 Dec 2022 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.03%
|
65,000
|
$104,000 | — | 31 Dec 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
58,765
|
$94,024 | — | 31 Dec 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
58,247
|
$93,194 | — | 31 Dec 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
56,281
|
$90,050 | — | 31 Dec 2022 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
53,243
|
$85,000 | — | 31 Dec 2022 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.02%
|
47,723
|
$76,000 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
45,800
|
$73,280 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
42,221
|
$67,554 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
42,009
|
$67,214 | — | 31 Dec 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
41,559
|
$66,494 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
36,152
|
$57,843 | — | 31 Dec 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
34,800
|
$55,680 | — | 31 Dec 2022 | |
| Man Group plc |
13F
|
Company |
0.02%
|
34,575
|
$55,320 | — | 31 Dec 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.02%
|
34,084
|
$54,534 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
33,103
|
$53,000 | — | 31 Dec 2022 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) as of Q1 2023
As of 31 Mar 2023,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,594,054 shares.
The largest 10 holders included
BVF INC/IL, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, Laurion Capital Management LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Bronte Capital Management Pty Ltd., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
77
Q1 2023 holders
74
Holder diff
-3
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.